GAITHERSBURG, Maryland (Reuters) - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children despite uncertainty about the risks of long-term use, U.S.

Testing Celebrex in children gave Pfizer, the world’s biggest drugmaker, six more months of patent protection, an incentive the FDA grants to companies to develop pediatric treatments. The safety of ...

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Drs. Donohue and Roach • I have arthritis in both knees and have taken Celebrex for years for it. I am unsure how long I ...

LOS ANGELES, Dec 15 (Reuters) - Pfizer Inc. > won U.S. approval on Friday to promote its Celebrex pain reliever for treating children age two and older who have rheumatoid arthritis, the Food and Drug ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Research suggests several popular ...

Pfizer announced Friday that it found the increased risk in one of two long-term cancer-prevention trials, while the other trial showed no increased risk. The company was conducting the trials as part ...